PULMONX CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.495 USD | +22.99% |
|
+30.07% | -25.53% |
| 01/05 | Earnings Flash (LUNG) PULMONX CORPORATION Posts Q1 Revenue $18.9M, vs. Street Est of $17.9M | MT |
| 01/05 | Transcript : Pulmonx Corporation, Q1 2024 Earnings Call, May 01, 2024 |
Chart calendar Pulmonx Corporation
966942b523c977a8a1.cYxC-V43no-vU_viIhuEPyb6AR0tZnTTUvMgP9wyYII.RO8ymh1m6cDIJbCob3XtTUKoVkpdLAaRMZESdoxYMsUixy2DLnTQ_N0Vog~356ccfa48c4cdaf1c891d02528b126d8
Upcoming events on Pulmonx Corporation
Past events on Pulmonx Corporation
| 02/05/2024 02:00 am | Q1 2024 Earnings Call |
| 02/05/2024 01:35 am | Q1 2024 Earnings Release |
| 22/02/2024 03:00 am | Q4 2023 Earnings Call |
| 22/02/2024 02:36 am | Q4 2023 Earnings Release |
| 30/11/2023 12:30 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 16/11/2023 | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
| 15/11/2023 12:55 am | Stifel Healthcare Conference |
| 31/10/2023 02:00 am | Q3 2023 Earnings Call |
| 31/10/2023 01:35 am | Q3 2023 Earnings Release |
| 06/09/2023 11:45 pm | Wells Fargo Healthcare Conference |
| 10/08/2023 12:30 am | Canaccord Genuity Growth Conference |
| 03/08/2023 02:00 am | Q2 2023 Earnings Call |
| 03/08/2023 01:35 am | Q2 2023 Earnings Release |
| 17/05/2023 08:30 pm | Annual General Meeting |
| 10/05/2023 04:25 am | Bank of America Healthcare Conference |
| 03/05/2023 02:00 am | Q1 2023 Earnings Call |
| 03/05/2023 01:35 am | Q1 2023 Earnings Release |
| 02/03/2023 11:45 pm | Citi Healthcare Services Medtech Tools & HCIT Conference |
| 23/02/2023 03:00 am | FY 2022 Earnings Call |
| 23/02/2023 02:35 am | FY 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 32,7 31,7 3.12% | 48,4 49,0 -1.2% | 53,7 52,1 2.91% | 68,7 67,6 1.53% | 82,7 |
|
EBITDA Million USD | Released Forecast Spread | -31,8 -31,9 0.06% | -46,4 -45,0 -3.13% | -57,1 -55,5 -2.9% | -60,4 -60,8 0.76% | -57,5 |
|
EBIT Million USD | Released Forecast Spread | -32,3 -32,5 0.44% | -47,3 -47,7 0.77% | -58,6 -59,4 1.33% | -61,9 -63,7 2.7% | -67,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,0 -32,0 0.05% | -48,3 -48,5 0.39% | -58,6 -60,3 2.85% | -60,3 -62,5 3.63% | -66,4 |
|
Net income Million USD | Released Forecast Spread | -32,2 -32,5 0.79% | -48,7 -48,8 0.29% | -58,9 -60,5 2.59% | -60,8 -62,9 3.35% | -65,3 |
|
EPS USD | Released Forecast Spread | -3,16 -4,09 22.74% | -1,35 -1,35 -0.3% | -1,59 -1,62 2.05% | -1,60 -1,66 3.61% | -1,73 |
| Announcement Date | 02/03/21 | 23/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13,7 14,2 -3.75% | 10,8 9,26 16.44% | 14,0 13,8 1.31% | 13,5 14,9 -9.59% | 15,4 14,0 10.3% | 14,5 13,5 7.72% | 17,2 15,9 8.4% | 17,7 16,9 4.54% | 19,3 18,2 5.67% | 18,9 17,9 5.53% | 20,3 | 20,7 | 23,1 | 22,6 |
|
EBITDA Million USD | Released Forecast Spread | -12,0 -11,9 -0.73% | -15,3 -11,5 -33.61% | -14,0 -14,6 3.98% | -13,5 -13,0 -4.45% | -14,2 -14,1 -1.07% | -16,0 -15,1 -5.84% | -16,0 -16,1 0.65% | -14,8 -14,1 -4.91% | -13,6 -15,0 9.39% | -14,1 -15,8 10.91% | -13,9 | -14,4 | -16,0 | |
|
EBIT Million USD | Released Forecast Spread | -12,4 -12,8 3.5% | -15,7 -13,2 -18.78% | -14,4 -14,7 1.93% | -13,9 -14,2 2.17% | -14,6 -15,6 6.37% | -16,4 -16,7 1.7% | -16,4 -16,7 1.59% | -15,2 -16,3 7.08% | -13,9 -15,6 10.97% | -14,5 -17,9 18.98% | -16,9 | -17,0 | -18,3 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,9 -13,1 1.81% | -15,8 -12,7 -23.64% | -14,6 -14,9 2.27% | -14,2 -14,4 1.49% | -14,0 -15,8 11.16% | -15,7 -17,0 7.23% | -16,1 -16,7 3.67% | -14,8 -16,3 9.08% | -13,6 -15,9 14.1% | -13,6 -17,6 23.09% | -16,5 | -16,9 | -18,4 | |
|
Net income Million USD | Released Forecast Spread | -13,0 -13,2 1.22% | -15,8 -13,6 -16.31% | -14,6 -15,1 2.93% | -14,2 -14,5 2.47% | -14,3 -15,8 9.67% | -15,9 -16,8 5.35% | -16,2 -16,7 3.24% | -14,9 -16,4 9.28% | -13,9 -16,0 13.08% | -13,7 -16,0 14.16% | -16,3 | -16,9 | -18,4 | -14,8 |
|
EPS USD | Released Forecast Spread | -0,35 -0,36 2.23% | -0,43 -0,37 -16.22% | -0,40 -0,40 0.99% | -0,38 -0,39 2.56% | -0,38 -0,42 9.52% | -0,42 -0,44 4.91% | -0,43 -0,45 3.59% | -0,39 -0,43 9.72% | -0,36 -0,42 13.46% | -0,36 -0,42 14.79% | -0,43 | -0,45 | -0,47 | -0,47 |
| Announcement Date | 23/02/22 | 03/05/22 | 02/08/22 | 03/11/22 | 22/02/23 | 02/05/23 | 02/08/23 | 30/10/23 | 21/02/24 | 01/05/24 | - | - | - | - |
| 06/05/2024 | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:39 am | SI-BONE, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | CHEMOMETEC A/S: Q3 2024 Earnings Release |
| 09/05/2024 | WON TECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 14/05/2024 | I-SENS, INC.: Q1 2024 Earnings Release (Projected) |
| 15/05/2024 | ASAHI INTECC CO., LTD.: Q3 2024 Earnings Release |
| 15/05/2024 | IMPLANTICA AG: Q1 2024 Earnings Release |
Past sector events for Pulmonx Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LUNG Stock
- Calendar Pulmonx Corporation
